Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending December 22, 2019 Vitamin D Alone Does Not Reduce Fracture Risk, Dose Escalation of Biosimilar Infliximab for RA Patients Deemed Cost Effective, to a Point, Ultrasound Improves Specificity of Psoriatic Arthritis Referrals, Osteoporotic Fracture Risk is Undermanaged in Older Adults, Well-Tolerated Topical Capsaicin Formulation Reduces Knee OA Pain, More must reads Must reads for theWeek ending December 15, 2019 House Passes Drug Pricing Bill, Likely Ending its Journey, Evidence Builds for Effects of Obesity, Low Physical Activity on Development of Psoriatic Arthritis, VEDOSS Study Describes Predictors of Progression to Systemic Sclerosis, ADA2 is a potent new biomarker for macrophage activation syndrome, Reduced Kidney Function Linked to Fractures in Older Women, More must readsMust reads for theWeek ending December 8, 2019 Certolizumab may reduce uveitis flares, axSpA disease activity, TULIP Trials Show Clinical Benefit of Anifrolumab for SLE, Health Care: More Uninsured As Insurance Costs Grow Faster, Upadacitinib Doubles ASAS 40 Response VS. Placebo in Ankylosing Spondylitis, Glucocorticoids Linked to Damage Accrual in SLE Regardless of Disease Activity, More must readsMust reads for theWeek ending November 24, 2019 Colchicine cut post-MI CVD events, Large Population-Based Study Underscores Link Between Gout, CVD Event Risk, SPIRIT-H2H Results Confirm Superiority of Ixekizumab Over Adalimumab for PsA, COAST-X Top-Line Results: Ixekizumab Improves Nonradiographic AxSpA VS. Placebo, Fewer people are dying from systemic sclerosis at younger ages, More must readsMust reads for theWeek ending November 24, 2019 Colchicine cut post-MI CVD events, Large Population-Based Study Underscores Link Between Gout, CVD Event Risk, SPIRIT-H2H Results Confirm Superiority of Ixekizumab Over Adalimumab for PsA, COAST-X Top-Line Results: Ixekizumab Improves Nonradiographic AxSpA VS. Placebo, Fewer people are dying from systemic sclerosis at younger ages, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 last »
